Orthofix Medical Inc. Common Stock (DE)
Orthofix Medical Inc. Common Stock (DE) (OFIX): 5 pipeline candidates · ~38 mo cash runway · 16 clinical trials. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
37.9 months
D/E 1.04 · 0% dilution
Lead: Approved
5 candidates
N/A
16 buys · 20 sells (180d)
A transparent, data-derived signal for Orthofix Medical Inc. Common Stock (DE)across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$376.3M
Cash
$120.3M
Quarterly Burn
$17.6M
Runway
37.9 mo
Revenue
$196.7M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (5 candidates)
| Drug | Phase |
|---|---|
| accelstim | Approved |
| cervicalstim | Approved |
| physiostim | Approved |
| spinal-stim spinal fusion system | Approved |
| spinalstim | Approved |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
143
Total value held
$286.9M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 3,310,898 | $38.0M |
| paradigm capital management inc/ny | 3,304,899 | $37.9M |
| blackrock, inc. | 3,207,789 | $36.8M |
| armistice capital, llc | 2,700,000 | $31.0M |
| millennium management llc | 1,066,900 | $12.2M |
| geode capital management, llc | 938,885 | $10.8M |
| state street corp | 907,432 | $10.4M |
| dimensional fund advisors lp | 841,521 | $9.7M |
| ayal capital advisors ltd | 783,689 | $9.0M |
| philosophy capital management llc | 558,901 | $6.4M |
Showing top 10 of 143 institutional holders of Orthofix Medical Inc. Common Stock (DE). Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Orthofix Medical Inc. Common Stock (DE)'s pipeline?
Orthofix Medical Inc. Common Stock (DE) (OFIX) has 5 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Orthofix Medical Inc. Common Stock (DE)'s lead drug candidate?
Orthofix Medical Inc. Common Stock (DE)'s most advanced tracked candidate is accelstim (Approved) for Nonunion fracture healing and accelerate the healing of indicated fresh fractures.
What is Orthofix Medical Inc. Common Stock (DE)'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Orthofix Medical Inc. Common Stock (DE) has approximately 37.9 months of cash runway.
What is Orthofix Medical Inc. Common Stock (DE)'s market capitalization?
Orthofix Medical Inc. Common Stock (DE)'s market capitalization is approximately $376.3M.
Who is the CEO of Orthofix Medical Inc. Common Stock (DE)?
Mr. Massimo Calafiore is the chief executive officer of Orthofix Medical Inc. Common Stock (DE) (OFIX).
Get the full picture on Orthofix Medical Inc. Common Stock (DE)
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.